Reactions Weekly

February 2019, Volume 1739, Issue 1, pp 67–67 | Cite as

Bevacizumab/oxaliplatin/ramucirumab

Thrombotic microangiopathy: case report

Case report

First Online: 09 February 2019

• 14 Downloads

This is a preview of subscription content, log in to check access.

Reference

1. Yamada R, et al. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: A case report. BMC Nephrology 20: No. 14, 11 Jan 2019. Available from: URL: http://doi.org/10.1186/s12882-018-1194-9 -Japan

Copyright information

© Springer Nature Switzerland AG 2019